SYNLOGIC, INC.
SYBXDrugs in Pipeline
2
Phase 3 Programs
0
Upcoming Catalysts
0
Next Catalyst
None scheduled
Market Overview
Stock performance and key metrics
0 upcoming, 0 past
No catalysts found.
Frequently asked questions
What is in SYNLOGIC, INC.'s drug pipeline?→
CatalystAlert tracks 2 drug candidates in SYNLOGIC, INC.'s (SYBX) pipeline across Phase 2. Its lead program is SYNB1934 (Phase 2). Each drug's phase, indication and upcoming catalysts are listed on this page.
When is SYNLOGIC, INC.'s next FDA catalyst?→
CatalystAlert tracks every upcoming catalyst for SYNLOGIC, INC. (SYBX) — PDUFA decision dates, Phase 1/2/3 trial readouts, FDA advisory committee meetings and NDA/BLA filings — each confidence-rated as confirmed, estimated or AI-detected.
How do I track SYBX biotech catalysts?→
Add SYBX to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow SYNLOGIC, INC.'s live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.